These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18266119)

  • 1. Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases.
    Sikkink LA; Ramirez-Alvarado M
    Amyloid; 2008 Mar; 15(1):29-39. PubMed ID: 18266119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.
    Blancas-Mejía LM; Martin EB; Williams A; Wall JS; Ramirez-Alvarado M
    Biophys Chem; 2017 Nov; 230():89-98. PubMed ID: 28916410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
    Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
    Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma.
    Kosaka M; Iishi Y; Okagawa K; Saito S; Sugihara J; Muto Y
    Am J Clin Pathol; 1989 Jun; 91(6):639-46. PubMed ID: 2499179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains.
    Davern S; Murphy CL; O'Neill H; Wall JS; Weiss DT; Solomon A
    Biochim Biophys Acta; 2011 Jan; 1812(1):32-40. PubMed ID: 20692337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
    Odani S; Komori Y; Gejyo F
    Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
    Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
    J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent fibrillogenesis of a VkappaIII Bence Jones protein.
    Rostagno A; Vidal R; Kaplan B; Chuba J; Kumar A; Elliott JI; Frangione B; Gallo G; Ghiso J
    Br J Haematol; 1999 Dec; 107(4):835-43. PubMed ID: 10606892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.
    Arosio P; Owczarz M; Müller-Späth T; Rognoni P; Beeg M; Wu H; Salmona M; Morbidelli M
    PLoS One; 2012; 7(3):e33372. PubMed ID: 22432016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition.
    Myatt EA; Westholm FA; Weiss DT; Solomon A; Schiffer M; Stevens FJ
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3034-8. PubMed ID: 8159701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association.
    Roussel A; Spinelli S; Déret S; Navaza J; Aucouturier P; Cambillau C
    Eur J Biochem; 1999 Feb; 260(1):192-9. PubMed ID: 10091599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary findings in renal light chain-derived amyloidosis and light chain deposition disease.
    Melmed GM; Fenves AZ; Stone MJ
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):234-8. PubMed ID: 19525193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro.
    Klafki HW; Pick AI; Pardowitz I; Cole T; Awni LA; Barnikol HU; Mayer F; Kratzin HD; Hilschmann N
    Biol Chem Hoppe Seyler; 1993 Dec; 374(12):1117-22. PubMed ID: 8129857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum test for assessment of patients with Bence Jones myeloma.
    Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT
    Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic modulation of light chain amyloid fibril formation.
    Kim Y; Wall JS; Meyer J; Murphy C; Randolph TW; Manning MC; Solomon A; Carpenter JF
    J Biol Chem; 2000 Jan; 275(3):1570-4. PubMed ID: 10636846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a Single Point Mutation in the Constant Domain of the Bence-Jones Protein bif on Its Aggregation Properties.
    Timchenko MA; Timchenko AA
    Biochemistry (Mosc); 2018 Feb; 83(2):107-118. PubMed ID: 29618297
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.